These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2412111)

  • 1. A monoclonal antibody (RH1-38) which inhibits multiple systems of cell-mediated cytotoxicity--II. Evidence that the epitope recognized is involved in a late step in the cytolytic mechanism.
    Hall RE; Schall RP; Black LA
    Mol Immunol; 1985 Jul; 22(7):765-73. PubMed ID: 2412111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody (RH1-38) which inhibits multiple systems of cell-mediated cytotoxicity--I. Identification of a novel epitope on a killer cell surface bimolecular complex important in the cytotoxic response.
    Hall RE
    Mol Immunol; 1985 Jul; 22(7):757-64. PubMed ID: 2412110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2 modulates the expression of lymphocyte function-associated antigen-one (LFA-1) and p150,95 during the generation of lymphokine-activated killer (LAK) cells.
    Grant AJ; Merchant RE; Hall RE
    Immunology; 1989 Jan; 66(1):117-24. PubMed ID: 15493273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME; Hiserodt JC
    J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping functional epitopes of the human LFA-1 glycoprotein: monoclonal antibody inhibition of NK and CTL effectors.
    Mentzer SJ; Krensky AM; Burakoff SJ
    Hum Immunol; 1986 Nov; 17(3):288-96. PubMed ID: 2432044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
    Dato ME; Kim YB
    J Immunol; 1990 Jun; 144(11):4452-62. PubMed ID: 1971298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte function-associated antigen 1 (LFA-1) and natural killer (NK) cell activity: LFA-1 is not necessary for all killer: target cell interactions.
    Hart MK; Kornbluth J; Main EK; Spear BT; Taylor J; Wilson DB
    Cell Immunol; 1987 Oct; 109(2):306-17. PubMed ID: 3311386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
    Kurago ZB; Lutz CT; Smith KD; Colonna M
    J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T11/CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules.
    Schmidt RE; Caulfield JP; Michon J; Hein A; Kamada MM; MacDermott RP; Stevens RL; Ritz J
    J Immunol; 1988 Feb; 140(3):991-1002. PubMed ID: 3276787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
    Uchida A; Vánky F; Klein E
    J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
    Uchida A; Klein E
    Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of human natural killer cell activity by interferon: conditions required for boosting and characteristics of the effector cells.
    Ortaldo JR; Lang NP; Timonen T; Herberman RB
    J Interferon Res; 1981 Feb; 1(2):253-62. PubMed ID: 6180056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition of a "trigger" stage in the NK cytolytic reaction sequence by a monoclonal antibody to the glycoprotein T-200.
    Targan SR; Newman W
    J Immunol; 1983 Sep; 131(3):1149-53. PubMed ID: 6886418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The isolation of natural killer (NK)-resistant variants of the K562 cell line by mutagenesis and selection with antibodies which inhibit NK cell-mediated lysis.
    Werkmeister JA; Triglia T; Burns GF
    Cell Immunol; 1985 Apr; 92(1):123-33. PubMed ID: 3865715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of irradiation-induced intercellular adhesion molecule-1 expression on natural killer cell-mediated cytotoxicity toward human cancer cells.
    Jeong JU; Uong TNT; Chung WK; Nam TK; Ahn SJ; Song JY; Kim SK; Shin DJ; Cho E; Kim KW; Cho D; Yoon MS
    Cytotherapy; 2018 May; 20(5):715-727. PubMed ID: 29572116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental regulation of a mucinlike glycoprotein selectively expressed on natural killer cells.
    Vivier E; Sorrell JM; Ackerly M; Robertson MJ; Rasmussen RA; Levine H; Anderson P
    J Exp Med; 1993 Dec; 178(6):2023-33. PubMed ID: 7504054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the CD45 (T-200) molecule in anti-CD3-triggered T cell-mediated cytotoxicity.
    Deem RL; Shanahan F; Niederlehner A; Targan SR
    Cell Immunol; 1988 Nov; 117(1):99-110. PubMed ID: 2972397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional surface structures on human natural killer cells.
    Schmidt RE; Hercend T; Schlossman SF; Ritz J
    Klin Wochenschr; 1985 Dec; 63(23):1189-200. PubMed ID: 2418257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of natural killer activity by the monoclonal antibodies OKT10 and VEP10 at the single cell level.
    Golightly MG; Koren HS; Travis WW; Brandt CP; Haynes BF; Kraft D; Rumpold H
    Cell Immunol; 1984 Oct; 88(2):382-92. PubMed ID: 6207942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.